Long term stability of paraoxonase-1 and high-density lipoprotein in human serum

被引:15
作者
Beekhof, Piet K. [1 ]
Gorshunska, Maryana [2 ]
Jansen, Eugene H. J. M. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands
[2] Kharkiv Postgrad Med Acad, Dept Endocrinol, UA-61176 Kharkov, Ukraine
关键词
Paraoxonase; High-density lipoprotein; Serum; Stability; Storage; PON1; DISEASE;
D O I
10.1186/1476-511X-11-53
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Background: Paraoxonase-1 (PON1) is an enzyme with numerous functions and receives an increasing interest in clinical and epidemiological studies. Sometimes samples are stored for longer periods at a certain temperature. Therefore the stability of PON1 activity must be checked and retained upon storage for longer periods. Results: In this study the stability of PON1 activity has been tested in human serum samples during storage up to 12 months at 3 commonly used temperatures, -20 degrees C, -70 degrees C and -196 degrees C. It was found that the stability of the PON1 activity is constant during 12 months of storage at -70 degrees C and -196 degrees C. Storage at -20 degrees C resulted in a small but statistically significant decrease after 6 months to about 94% of its original value. Nonetheless, the rank order between the samples at T = 0 and 12 months remained the same. The same temperature dependence was found for the associated high-density lipoprotein. Conclusions: It can be concluded that -70 degrees C is the right temperature for storage to maintain the PON1 activity for at least one year. Storage at a lower temperature in liquid nitrogen (-196 degrees C) is not necessary.
引用
收藏
页数:3
相关论文
共 12 条
[1]
Decreased Paraoxonase and Arylesterase Activities in the Pathogenesis of Future Atherosclerotic Heart Disease in Women with Gestational Diabetes Mellitus [J].
Camuzcuoglu, Hakan ;
Toy, Harun ;
Cakir, Hale ;
Celik, Hakim ;
Erel, Ozcan .
JOURNAL OF WOMENS HEALTH, 2009, 18 (09) :1435-1439
[2]
Human PON1, a biomarker of risk of disease and exposure [J].
Furlong, C. E. ;
Suzuki, S. M. ;
Stevens, R. C. ;
Marsillach, J. ;
Richter, R. J. ;
Jarvik, G. P. ;
Checkoway, H. ;
Samii, A. ;
Costa, L. G. ;
Griffith, A. ;
Roberts, J. W. ;
Yearout, D. ;
Zabetian, C. P. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 187 (1-3) :355-361
[3]
The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux [J].
Gaidukov, Leonid ;
Rosenblat, Mira ;
Aviram, Michael ;
Tawfik, Dan S. .
JOURNAL OF LIPID RESEARCH, 2006, 47 (11) :2492-2502
[4]
Q192R polymorphism of PON-1 gene in type 2 diabetes patients [J].
Gorshunskaya, M. Yu ;
Karachentsev, Yu I. ;
Atramentova, L. A. ;
Tyzhnenko, T. V. ;
Kravchun, N. A. ;
Pochernyaev, A. K. ;
Poltorak, V. V. .
CYTOLOGY AND GENETICS, 2011, 45 (01) :38-40
[5]
Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis [J].
Gugliucci, Alejandro ;
Kinugasa, Eriko ;
Kotani, Kazuhiko ;
Caccavello, Russell ;
Kimura, Satoshi .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (01) :61-67
[6]
Validation of PON1 enzyme activity assays for longitudinal studies [J].
Huen, Karen ;
Richter, Rebecca ;
Furlong, Clement ;
Eskenazi, Brenda ;
Holland, Nina .
CLINICA CHIMICA ACTA, 2009, 402 (1-2) :67-74
[7]
The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins [J].
Loued, Soumaya ;
Isabelle, Maxim ;
Berrougui, Hicham ;
Khalil, Abdelouahed .
LIFE SCIENCES, 2012, 90 (1-2) :82-88
[8]
Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity [J].
Mackness, Mike ;
Mackness, Bharti .
CLINICAL BIOCHEMISTRY, 2011, 44 (14-15) :1270-1271
[9]
Paraoxonase I interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development [J].
Tavori, Hagai ;
Rosenblat, Mira ;
Vaya, Jacov ;
Aviram, Michael .
CLINICAL LIPIDOLOGY, 2010, 5 (05) :685-697
[10]
Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study) [J].
Van den Berg, S. W. ;
Jansen, E. H. J. ;
Kruijshoop, M. ;
Beekhof, P. K. ;
Blaak, E. ;
Van der Kallen, C. J. ;
Van Greevenbroek, M. M. ;
Feskens, E. J. M. .
DIABETIC MEDICINE, 2008, 25 (02) :186-193